Soluble CD30 serum level in HCV-positive chronic active hepatitis: A surrogate marker of disease activity?

Cytokine

Volumn 12, Issue 6, 2000, Pages 815-818

  Foschi, F G ^a   Gramenzi, A ^a   Castelli, E ^a   Cursaro, C ^a   Pagani, S ^a   Margotti, M ^a   D'Errico, A ^a   Andreone, P ^a   Stefanini, G F ^b   Bernardi, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Ospedale di Faenza   (Italy)

Author keywords

CD30; Chronic hepatitis; Hepatitis C virus; Lymphocytes; Th1; Th2 response

Indexed keywords

ALANINE AMINOTRANSFERASE; CD30 ANTIGEN; CYTOKINE; GLYCOPROTEIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEPATITIS C; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE ACTIVATION; TH2 CELL;

HEPATITIS C VIRUS;

EID: 0033948532     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0653     Document Type: Article

References (15)

1. Romagnani S. Short analytical review, Th1 and Th2 in human diseases. Clin Immunol Immunopathol. 80:1996;225-235.
2. Del Prete G, Maggi E, Pizzolo G, Romagnani S. CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol Today. 16:1995;76-80.
3. Penna A, Del Prete G, Cavalli A, Bertoletti A, D'Elios MM, Sorrentino R, D'Amato M, Boni C, Pilli M, Fiaccadori F, Ferrari C. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limitated hepatitis B. Hepatology. 25:1997;1022-1027.
4. Paul W, Seder RA. Lymphocyte response and cytokines. Cell. 76:1994;241-251.
5. Tsai SL, Liaw YF, Chen MH, Huang CY, Kuo GC. Detection of type 2-like T helper cells in hepatitis C virus infection: implication for hepatitis C virus chronicity. Hepatology. 25:1997;449-458.
6. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi MG, Houghton M, Fiaccadori F, Ferrari C. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the antiviral cell-mediated immune response. J Clin Invest. 98:1996;706-714.
7. Nelson DR, Lau JYN. Host immune response in hepatitis C virus infection. Viral Hepatitis. 2:1992;37-48.
8. 1T cells producing Th-2 type of Cytokine. FASEB. 9:1995;81-86.
9. Fattovich G, Vinante F, Giustina G, Morosato L, Alberti A, Ruol A, Pizzolo G. Serum level of soluble CD30 in chronic hepatitis B virus infection. Clin Exp Immunol. 103:1996;105-110.
10. Woitas RP, Lechmann M, Jung G, Kaiser R, Sauerbruch T, Spengler U. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes. J Immunol. 159:1997;1012-1018.
11. Napoli J, Bishop GA, McGuinnes P, Painter DM, McCaughan G. Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines. Hepatology. 24:1996;759-765.
12. +T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med. 178:1993;17-25.
13. Hamman D, Hilkens CMU, Grogan JL, Lens SMA, Kapsenberg ML, Yazdanbakhsh van Lier RAW. CD30 expression does not discriminate between human Th1 and Th2 type T cells. J Immunol. 156:1996;1387-1391.
14. Gruss HJ, Boiani N, Williams, Armitage RJ, Smith CA, Goodwin RG. Pleiotropic effects of the CD30 ligand on CD30-expressing cell and lymphoma cell lines. Blood. 83:1994;2045-2056.
15. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 19:1994;1513-1520.